Kami Maddocks, Md
Clinical trials sponsored by Kami Maddocks, Md, explained in plain language.
-
New hope for tough blood cancers: targeted pill shows promise in advanced leukemia
Disease control OngoingThis study tests a daily pill called ibrutinib in 154 people with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or B-cell prolymphocytic leukemia (B-PLL) that has come back or stopped responding to other treatments. The goal is to see how well the drug con…
Phase: PHASE2 • Sponsor: Kami Maddocks, MD • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New hope for relapsed lymphoma: drug cocktail targets cancer cells
Disease control OngoingThis early-stage trial tests a new drug (PCI-32765) combined with two standard treatments (rituximab and bendamustine) in 48 adults with relapsed non-Hodgkin lymphoma. The goal is to find the safest dose and see how well the combination works. Participants have specific types of …
Phase: PHASE1 • Sponsor: Kami Maddocks, MD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC